Skip to main content

HighVista Strategies LLC

Source: SEC Form 13F · as of Mar 2026

HighVista Strategies LLC holds 54 biotech & pharma companies tracked by BioSniper, totaling $179.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

54

Total value held

$179.4M

BioSniper AIPage context preserved

Prepared research question

What matters most for Abivax SA (ABVX)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
ABVXAbivax SA113,254$12.6M
COGTCogent Biosciences, Inc.197,051$7.6M
SYRESpyre Therapeutics, Inc.146,264$7.4M
PCVXVaxcyte, Inc.124,647$7.2M
RVMDREVOLUTION MEDICINES, INC.69,309$6.7M
TERNTerns Pharmaceuticals, Inc.114,307$6.0M
GPCRStructure Therapeutics Inc.123,909$6.0M
NUVLNuvalent, Inc.56,602$5.8M
IMVTImmunovant, Inc.225,139$5.6M
SLNOSOLENO THERAPEUTICS INC165,227$5.5M
LBRXLB PHARMACEUTICALS INC173,595$4.3M
RLAYRelay Therapeutics, Inc.421,881$4.2M
INSMINSMED Inc24,316$4.0M
ORKAOruka Therapeutics, Inc.78,911$3.9M
CYTKCYTOKINETICS INC58,643$3.9M
LQDALiquidia Corp99,744$3.8M
OCULOCULAR THERAPEUTIX, INC441,573$3.7M
BBIOBridgeBio Pharma, Inc.49,560$3.7M
MLTXMoonLake Immunotherapeutics193,955$3.6M
ARGXARGENX SE4,918$3.6M
PTGXProtagonist Therapeutics, Inc33,852$3.6M
DFTXDefinium Therapeutics Inc.185,856$3.5M
NRIXNurix Therapeutics, Inc.226,546$3.5M
AXSMAxsome Therapeutics, Inc.20,437$3.5M
IVAInventiva S.A.615,666$3.4M
APGEApogee Therapeutics, Inc.35,761$3.0M
GHRSGH Research PLC213,212$3.0M
DNTHDianthus Therapeutics, Inc. /DE/35,587$3.0M
MAZEMaze Therapeutics, Inc.99,850$3.0M
ELVNEnliven Therapeutics, Inc.73,102$2.9M
CLDXCelldex Therapeutics, Inc.89,397$2.8M
PHVSPharvaris N.V.97,866$2.8M
VRDNViridian Therapeutics, Inc.\DE134,229$2.6M
ALMSALUMIS INC.112,929$2.5M
TNGXTango Therapeutics, Inc.104,193$2.2M
ASMBASSEMBLY BIOSCIENCES, INC.74,735$2.1M
JAZZJazz Pharmaceuticals plc10,838$2.0M
STOKStoke Therapeutics, Inc.62,617$2.0M
CMPSCOMPASS Pathways plc364,360$2.0M
IMCRImmunocore Holdings plc58,697$1.8M
OLMAOlema Pharmaceuticals, Inc.117,601$1.8M
KODKodiak Sciences Inc.43,569$1.7M
XOMAXOMA Royalty Corporation46,814$1.5M
RYTMRHYTHM PHARMACEUTICALS, INC.16,796$1.5M
SVRASavara Inc250,999$1.4M
CTMXCytomX Therapeutics, Inc.288,057$1.4M
TVTXTravere Therapeutics, Inc.36,325$1.1M
NKTRNEKTAR THERAPEUTICS14,555$1.0M
AVTXAvalo Therapeutics, Inc.58,622$875K
ZYMEZymeworks Inc.34,085$853K
PVLAPALVELLA THERAPEUTICS, INC.5,903$736K
BBOTBridgeBio Oncology Therapeutics, Inc.78,187$700K
NAMSNEWAMSTERDAM PHARMA CO N.V.20,067$642K
CNTACentessa Pharmaceuticals plc5,964$237K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.